Gladstone Institutional Advisory’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,926
| Closed | -$466K | – | 713 |
|
|
2024
Q2 | $466K | Buy |
+3,926
| New | +$466K | 0.02% | 439 |
|
|
2023
Q4 | – | Sell |
-2,176
| Closed | -$225K | – | 684 |
|
|
2023
Q3 | $225K | Buy |
2,176
+368
| +20% | +$38K | 0.01% | 554 |
|
|
2023
Q2 | $220K | Sell |
1,808
-150
| -8% | -$18.2K | 0.01% | 584 |
|
|
2023
Q1 | $301K | Sell |
1,958
-32
| -2% | -$4.91K | 0.02% | 522 |
|
|
2022
Q4 | $357K | Sell |
1,990
-363
| -15% | -$65.2K | 0.03% | 465 |
|
|
2022
Q3 | $278K | Sell |
2,353
-64
| -3% | -$7.56K | 0.02% | 517 |
|
|
2022
Q2 | $345K | Sell |
2,417
-2,863
| -54% | -$409K | 0.03% | 478 |
|
|
2022
Q1 | $910K | Sell |
5,280
-1,707
| -24% | -$294K | 0.06% | 309 |
|
|
2021
Q4 | $1.78M | Sell |
6,987
-401
| -5% | -$102K | 0.14% | 200 |
|
|
2021
Q3 | $2.84M | Sell |
7,388
-858
| -10% | -$330K | 0.28% | 101 |
|
|
2021
Q2 | $1.94M | Buy |
8,246
+6,651
| +417% | +$1.56M | 0.23% | 110 |
|
|
2021
Q1 | $209K | Sell |
1,595
-4,950
| -76% | -$649K | 0.03% | 379 |
|
|
2020
Q4 | $684K | Sell |
6,545
-2,369
| -27% | -$248K | 0.14% | 133 |
|
|
2020
Q3 | $631K | Sell |
8,914
-14,880
| -63% | -$1.05M | 0.15% | 126 |
|
|
2020
Q2 | $1.53M | Buy |
23,794
+14,766
| +164% | +$948K | 0.39% | 63 |
|
|
2020
Q1 | $270K | Buy |
+9,028
| New | +$270K | 0.07% | 205 |
|